Wednesday, February 10, 2010, 7:38pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEFINANCE NEWS
    Market:       |  

Medicines Co. (MDCO)

At 5:00AM SGT: 7.66 USD   0.00 (0.00%)  
 MORE ON MDCO 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 The Medicines Company (NasdaqNM:MDCO) Delayed quote dataEdit
Last Trade:7.66 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:7.66
Open:N/A
Bid:6.85 x 100
Ask:9.35 x 200
1y Target Est:10.20
Day's Range:N/A - N/A
52wk Range:6.15 - 14.34
Volume:0
Avg Vol (3m):337,336
Market Cap:404.99M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add MDCO to Portfolio   Download Data

 HEADLINES 
For US Audiences Only: The Medicines Company to Announce Fourth Quarter and Full Year 2009 Financial Results on Wednesday, February 17, 2010
Marketwire (Wed 5:30am)
In Depth: 10 Questions About High Cholesterol
at Forbes.com (Thu, Feb 4)
MEDICINES CO /DE Files SEC form 8-K, Other Events
EDGAR Online (Fri, Jan 29)
Biotech's Latest Failed Trials, Mishaps and Missed Targets
at Seeking Alpha (Mon, Jan 18)
The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635
Marketwire (Sat, Jan 16)
UPDATE - Medicines Co cuts 10 pct jobs, sees charges
at Reuters (Tue, Jan 12)
MEDICINES CO /DE Files SEC form 8-K, Costs Associated with Exit or Disposal Activities
EDGAR Online (Tue, Jan 12)
Pfizer's Having a Garage Sale
at Motley Fool (Sat, Jan 9)
The Medicines Company to Participate in the 28th Annual JP Morgan Healthcare Conference
Marketwire (Wed, Jan 6)
Medicines Co. suing Teva, Pliva again over patent
AP (Tue, Jan 5)
The Medicines Company Files Additional Patent Infringement Lawsuits
Marketwire (Tue, Jan 5)
More Headlines for MDCO...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.21
EPS Est (in 2 years) (Dec-10) :0.27
Avg Rec (current)*:2.7
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
The Medicines Company, a pharmaceutical company, provides medicines for the treatment of critical care patients worldwide. It markets Angiomax, an intravenous direct thrombin inhibitor for use as an anticoagulant in combination with aspirin in pat...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
Latest NewsSingapore Indices